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1. Introduction
Infection is one of the most devastating complications of total knee arthroplasty. It is also the
leading cause of early revision after knee arthroplasty, ahead of instability and aseptic
loosening [1].
Treatment of an infected total knee arthroplasty requires 3 to 6 times more hospital resources
than a primary arthroplasty and 2 times more than an aseptic revision [2]. The goal of treatment
is to eradicate infection and maintain joint function.
Two-stage exchange remains the treatment of choice in cases of late infection, with good or
excellent results in 80% to 100% of cases; nevertheless, it is aggressive, costly, and long. It is
also considered the treatment of choice in cases of fungal infection, infection by virulent
organisms, inflammatory diseases, immunosuppression, and reinfection after reimplantation.
Compared with direct replacement, 2-stage revision of infected arthroplasty has several
disadvantages: longer hospital stay, higher cost, longer surgical time, tissue retraction,
instability, and functional limitation between procedures. From a technical standpoint,
surgical reimplantation may be hampered by retraction of soft tissue and loss of tissue planes.
Most authors agree that almost all of these problems can be minimized using antibiotic-loaded
articulating cement spacers, although 2-stage exchange can be used to eradicate infection both
with and without cement spacers.
The most consistent results have been published with 2-stage exchange, regardless of varia‐
tions in the type of spacer, causal microorganism, or duration of infection. In a systematic
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review of the literature between 1980 and 2005, Jämsen et al. [3] found 31 original articles
describing the results of 154 direct exchanges and 926 2-stage exchanges. Eradication rates
were 73%-100% for 1-stage exchange and 82%-100% for 2-stage exchange. Final range of
motion and reinfection rates were lower in the series that used antibiotic-loaded articulating
spacers. No correlation was observed with the type of spacer or functional outcome between
direct revision and 2-stage exchange.
2. Spacer types: Nonarticulating and articulating
The 2-stage exchange protocol was designed by Insall in 1983. Since the first report in 1990,
long-term results have shown two-stage exchange to be the treatment of choice for infection
after total knee arthroplasty [4]. The outcome of the original procedure was poor to fair in 20%
of cases, mainly owing to functional disability and retraction of soft tissue. Atrophy, stiffness,
bone loss, and increased extensile exposure were observed at reimplantation.
The use of antibiotic-loaded articulating spacers helped to reduce these complications and
improve the possibilities of eradicating infection [5-9]. The choice of spacer depends on many
factors, including degree of bone loss, state of the soft tissue, choice of antibiotics, and financial
and technical restraints. A benefit that is common to both articulating and nonarticulating
antibiotic-loaded spacers is the fact that greater intra-articular levels of antibiotic can be
delivered than with parenteral antibiotics [10-11].
The approach aims to be above breakpoint sensitivity (ie, the level of antibiotic that sets the
boundary between bacterial susceptibility and the development of resistance) and to eradicate
infection.
Nonarticulating spacers enable local administration of a high concentration of antibiotic,
improve patient autonomy, facilitate outpatient treatment, and maintain the joint space for
future procedures.
Borden and Gearen [5], Booth and Lotke [7], and Cohen et al. [12] reported data for antibiotic-
loaded beads and cement spacers, which are molded to adapt to the defect created by removal
of the infected prosthesis. Although in some cases these authors made the spacer in 2 semi‐
blocks, thus forming a partial joint, neither the design of the blocks nor the rehabilitation
protocol included controlled mobility. Calton et al. [9] modified this approach, although
disadvantages were still observed (eg, bone loss when the spacer sank into the tibia).
Other disadvantages of this system are the minimal range of motion of the joint, which can
lead to shortening of the quadriceps, capsule, and ligaments, thus increasing the need for
extensile approaches with longer surgical time during reimplantation.
Antibiotic-loaded articulating cement spacers can improve function between operations and
facilitate the second stage.
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Although this approach remains open to debate, most authors agree that articulating spacers
provides better functional results and enable more efficacious eradication of infection than
nonarticulating spacers [3], [13-15].
The shape and features of articulating spacers vary considerably, from fully manual spacers
made in preformed molds to modular spacers, which include plastic and metal surfaces.
Spacers differ in price, complexity, and degree of constraint. The advantages of articulating
spacers are as follows: retraction of soft tissue and extensor mechanisms is prevented, high
doses of antibiotics can be added in the time between operations, bone mass is preserved better
than with nonarticulating spacers[9], [16], the need for expanded approaches at reimplantation
is reduced, and the success rate is increased. These approaches also enable greater controlled
mobility of the joint and application of a partial support brace, thus facilitating acceptable
function between procedures.
3. Historical development of articulating spacers
Use of antibiotic-loaded articulating spacers was first reported by Wilde and Ruth [6] in 1988.
This was the first attempt to reduce complications due to functional disability between
operations, as observed in the initial work by Windsor and Insall [4].
Preformed articulating systems (PROSTALAC®) first appeared in 1992. Their main advantage
was excellent tolerability and function between procedures, thanks to high joint congruence
and reduced friction [17]. Their disadvantages include high cost, presence of metal and plastic
surfaces that could facilitate bacterial growth, and size limitations. Preformed articulating
systems are not widely used because of their price and the theoretical risk that the presence of
metal and plastic components facilitates persistence of infection, although this has not been
confirmed in clinical practice. Therefore, other factors (eg, aggressiveness of the microorgan‐
ism, addition of high proportions of cement, and antibiotic treatment) may be more important
than the type of spacer used.
Hand-made cement articulating spacers, however, maintain almost all the advantages of
preformed spacers, although they also have a series of drawbacks.
Between these extremes, many authors have developed modifications to minimize the
disadvantages of hand-made spacers and PROSTALAC® spacers, by adapting them to their
technical and economic possibilities. The real impact of the theoretical advantages of the
different types of spacer is unknown.
The main forms are as follows:
1. Manual construction of a spacer with cement in the operating room by recreating the
normal anatomy of the patient [18], [19] (Figure 1 ) or more congruent systems (ball and
socket) [20] (Figure 2).
2. Construction of customized spacers in the operating room using prefabricated silicone or
aluminum molds [21], [22], or using trial components to shape the spacer [23]. Cement
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molds can be made during surgery using trial components, and the definitive spacer can
be made using these cement molds [24], [25].
3. Prefabricated spacers made of cement only [26].
4. Cement components in combination with modular components made of plastic and metal
(PROSTALAC®, DePuy, Warsaw, Indiana) [27], [28].
5. Resterilization of the prosthesis and insertion of a femoral component and a tibial
polyethylene insert with cement or a new prosthesis as a spacer (prosthesis-spacer) with
high antibiotic loads [29], [30].
6. Combinations of these approaches for moderate or massive defects [31], [32].
Figure 1. Remodeling prominent areas of a hand-made spacer with a high-speed burr.
Favorable results have been reported with each of these types of spacers. The more rudimen‐
tary a spacer is, the lower its congruence and the greater the sensation of popping, giving way,
or instability. In contrast, it is cheaper, more widely available, and versatile. The specific
advantage of spacers built manually with cement only is that the whole spacer is loaded with
antibiotics, and these can be tailored to the causative organism. The spacer does not include
plastic, metal, or resterilized parts and can be applied in any operating room with no need for
specific instruments. The main disadvantage of cement spacers is the lack of optimal congru‐
ence, instability, and the difficulty in modeling, especially with high antibiotic loads
(>10%-15%) (Figure3). In addition, cement-on-cement spacers can cause more inflammatory
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reactions as a result of particle generation; however, this has not been considered a real
problem in published series [18], [21], [24].
Figure 2. Ball and socket spacer.
Figure 3. Hand-made spacer for a segmental defect. Excellent range of motion. Due to instability or giving way the
patients usually walks with a brace.
Articulating Spacers in Infection of Total Knee Arthroplasty — State of the Art
http://dx.doi.org/10.5772/53243
559
Customized spacers constructed completely of cement using prefabricated silicone or alumi‐
num molds are not difficult to shape with greater antibiotic loads.
By contrast, preformed spacers including metal or plastic elements or resterilized prostheses
have a limited antibiotic load, which is not tailored to the patient. These spacers involve the
insertion of foreign material into a septic environment. In these cases, only the cement fixing
the metal components, the prosthesis, or the preformed spacer takes the maximum load of
tailored antibiotics.
Also important is the degree of constriction of the spacer. All spacers made intraoperatively
with a mold design lack a tibial post and femoral bar; at most, they have a tibial post that gives
them some medial-lateral stability. The bar, or lever, which provides anteroposterior stability,
is exclusive to PROSTALAC® systems or prosthesis-spacers.
4. Characteristics of antibiotic-loaded spacers
Elution of antibiotics from bone cement depends on several factors: the type of antibiotic, the
concentration and combination of antibiotics, the porosity and type of the cement, and the
surface of the spacer [33], [34].
4.1. Cement type: Commercially available vs. custom antibiotic-loaded cement
Most commercially available antibiotic-loaded cements, have a low dose of antibiotic, which
can act as prophylaxis in patients at risk (ie, double prophylaxis in combination with parenteral
antibiotics), or during reimplantation in a 2-stage revision of an infected total knee arthro‐
plasty, but not for the treatment of infection when it is diagnosed[35].
Therefore, surgeons should add antibiotics to the cement to achieve the appropriate doses
needed for the treatment of periprosthetic joint infection and to tailor the drug to the causative
microorganism.
In comparison with commercial presentations, manually mixed cement releases less antibiotic
[33], [34].
Manual mixing of cement and antibiotics increases the porosity of the cement. In theory, this
approach weakens the cement, but increases the elution surface, since the antibiotic is released
from the surface of the spacer and from cracks in the surface. On the other hand, distribution
is not homogeneous (unlike commercially available preloaded cements), thus decreasing the
rate of elution from a given surface [36], [37]. One study showed that increasing the surface
area of bone cement by 40% yielded a 20% increase in the elution rate of vancomycin [38].
The addition of dextran increases porosity and elution rates. Kuechle et al. [39] noted that when
dextran was added at 25%, the release of antibiotics during the first 48 hours was about 4 times
greater, and the duration of elution reached 10 days instead of only 6, compared with the
routine preparation. The same effect was observed with the addition of lactose and xylitol (or
other sugars), which increase the release of daptomycin, vancomycin, and gentamicin [33].
Arthroplasty - Update560
Vacuum mixing decreases the porosity of the cement and thus potentially decreases the elution
rate. However, this is not true for all cements, because other factors, such as hydrophilicity or
viscosity, may be more important than the area of elution.
In a recent study, Meyer et al. [34] compared the elution of 6 commercially available vacuum-
mixed and manually mixed antibiotic-loaded cements. All showed detectable antimicrobial
activity during the 5 days of the trial, with peak activity on the first day and levels above
breakpoint sensitivity. Levels decreased rapidly thereafter. Cumulative antimicrobial activity
during the trial was similar with the manually mixed Cemex Genta and the vacuum-mixed
Cobalt G-HV and Palacos RG and higher than that of VersaBond AB, Simplex P with Tobra‐
mycin, and SmartSet GMV. The cumulative antimicrobial activity of manually mixed Cemex
Genta over 5 days was significantly higher than that of Cobalt G-HV and Palacos RG, which
in turn significantly higher cumulative antimicrobial activity than VersaBond AB, Simplex P
with Tobramycin, and SmartSet GMV. Vacuum mixing increased the cumulative antimicrobial
activity of Cobalt G-HV, Palacos RG, and Simplex P with Tobramycin and decreased the
activity of Cemex Genta, SmartSet GMV, and VersaBond AB. The antimicrobial activity was
similar for Cobalt G-HV and Palacos RG and significantly higher than that of the other cements.
Furthermore, vacuum mixing also increased the number of days of elution above the break‐
point sensitivity necessary to eliminate 99% of methicillin-susceptible Staphylococcus aureus
(MSSA) and methicillin-resistant S. aureus (MRSA) and 85% of coagulase-negative staphylo‐
cocci (CNS) recorded between 2009 and 2010. For Palacos RG, the number of days of elution
increased from 2 days for manually mixed cements to 5 days for vacuum-mixed cements. For
Cobalt G-HV, this value increased from 2 to 3 days; for Simplex P with Tobramycin it increased
from 1 to 2 days. By contrast, vacuum mixing reduced the number of days’ elution above this
limit for Cemex Genta from 3 days to 1 day. The authors concluded that vacuum mixing had
adverse effects on elution with low-viscosity cement (Cemex Genta), positive effects on elution
with high-viscosity cements (Cobalt G-HV and Palacos RG), and unpredictable effects on
elution with medium-viscosity cements (Simplex P with Tobramycin, SmartSet GMV, and
VersaBond AB). Only manually mixed Cemex Genta and vacuum-mixed Palacos RG eluted
antibiotics above breakpoint sensitivity on the third day; the remainder did so only on the first
day. Although Cobalt G-HV and Palacos RG have a lower gentamicin load, they have greater
antimicrobial activity and elution rates than other cements with a higher antibiotic load.
Other studies confirm differences between cements. Stevens et al. [40] studied the in vitro
elution of antibiotics from Simplex and Palacos cements and noted that Palacos was a more
effective vehicle for local administration [41], [42].
4.2. Choice of antibiotic
Antibiotic-loaded cement spacers release high concentrations of drug and enable higher intra-
articular concentrations to be reached than parenteral antibiotics alone, with little effect on
serum or urine concentrations and therefore with minimal risk of systemic damage [29], [43],
[44]. It is essential to achieve local bactericidal concentrations that make it possible to eradicate
infection or prevent colonization of the new implant during the reimplantation phase (the "race
for the surface").
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The antibiotic used must have 2 fundamental properties:
• Thermostability: Polymerization of the cement is an exothermic reaction. The cement
increases in temperature within 10-13 minutes, and this change may alter the properties of
the antibiotic.
• Water solubility: The antibiotic is disseminated in the tissues surrounding the infected joint.
By maintaining the spacer in the joint for no less than 8 weeks, the antibiotic is released at
a constant rate. However, the bactericidal effect is concentrated in the early days. Subse‐
quently, spacers fulfill mainly a mechanical function.
The most frequently used antibiotics are tobramycin, gentamicin, vancomycin, and cephalo‐
sporins. Antibiotics can be combined to achieve broad-spectrum coverage, depending on the
nature of the causative microorganism. Aminoglycoside in powder is recommended, as it does
not weaken the cement; however, it is difficult to obtain in some countries. The surgeon’s
options are therefore limited when combining antibiotics.
Periprosthetic infections are caused mainly by gram-positive microorganisms (S. aureus and
CNS). When the pathogen and its antibiotic sensitivity profile are clearly identified, a single
antibiotic should be administered. When the pathogen is unknown, treatment is more difficult,
and a combination of antibiotics can improve the chances of eradicating infection. Vancomycin
covers MRSA, gentamicin covers Enterobacteriaceae and Pseudomonas aeruginosa, and cefo‐
taxime destroys microorganisms resistant to gentamicin.
In addition to increasing the range of coverage, some combinations of antibiotics have a
synergistic effect. Penner et al. [41] observed that the combination of vancomycin and tobra‐
mycin acted synergistically, although they discouraged the use of vancomycin in monother‐
apy. However, other authors have reported excellent results for CNS and MRSA with cement
loaded with only 5-7.5% vancomycin (Simplex P, Howmedica, Rutherford, New Jersey, USA:
2-3 g of vancomycin per bag), both in static and in articulating spacers [45].
Synergy between aminoglycosides and vancomycin and, occasionally, a cephalosporin can
make it possible to cover a broad spectrum of microorganisms. These antibiotics are usually
available in powder form; however, antibiotic-loaded cements are not commercially available.
Heraeus are working on a commercial presentation of gentamicin with vancomycin for
commercial use in Europe in 2012.
The only commercial presentation with a synergistic effect is Copal, which combines clinda‐
mycin and gentamicin. Copal enables increased release of antibiotic and greater ability to
inhibit the formation of biofilm than gentamicin alone. Ensing et al. [46] showed that the elution
rate of Copal (clindamycin + gentamicin) is much greater than that of other cements, which
are also considered excellent [47]. At 7 days, the elution rate was 65% for clindamycin and 41%
for gentamicin; for Palacos RG the value for release was 4% for preloaded gentamicin. This
increased release of antibiotic resulted in greater and more prolonged inhibition of bacterial
growth on agar plates. Gentamicin-susceptible S. aureus strains were "small colony variants"
that were resistant to gentamicin in Palacos RG and less so to the gentamicin in Copal. Elution
of gentamicin in Palacos RG ceased after 72 hours, in contrast with Copal, which maintained
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bacterial inhibition during the study period. In addition, unlike Copal, Palacos RG was unable
to inhibit bacterial growth of gentamicin-resistant CNS. The addition of clindamycin to
gentamicin-loaded cement had an additive effect on the inhibition of biofilm. Conversely,
although both cements fulfill ISO norms, the mechanical properties of Palacos RG are superior.
The study by Ensing et al. [46] has several practical implications. Synergy can enable the release
of greater amounts of antibiotic, thus making inhibition of bacterial growth more effective and
increasing the chances of winning the “race for the surface”. By achieving high rates of
antibiotic elution, even resistant bacteria can be eradicated when the dose rises sufficiently.
Finally, given its worse biomechanical properties, Copal seems ideal for articulating spacers,
which are withdrawn after a few weeks, but not as appropriate as Palacos RG for definitive
reimplantation once the infection has been cured.
Effective elution from cement has also been observed with quinolones, daptomycin, and
linezolid, although these agents are difficult to obtain in powder form or are too expensive
[48]. Anguita-Alonso et al. [48] compared quinolones, cefazolin, and linezolid and found
linezolid to be the most stable antibiotic after polymerization of PMMA. It achieved high peak
concentrations at 7.5% and 15%. All detectable concentrations of linezolid were always above
the cutoff sensitivity of Staphylococcus spp. (≤4 μg/mL).
Daptomycin has also demonstrated the ability to elute in local bactericidal concentrations for
S. aureus and CNS, with a release profile similar to that of vancomycin [39], [49], [50].
4.3. Fungal infections
In the case of fungal infections, the recommended antibiotic is amphotericin B or fluconazole
(Figure 4). 5-Flucytosine is not stable and is therefore not valid for use in cement. Amphotericin
can cause nephrotoxicity, hepatotoxicity, chills, nausea, and blood disorders, thus necessitat‐
ing lower doses and more prolonged treatment. Fortunately, the incidence of fungal infection
is low. Most infections are by Candida species, of which C. albicans accounts for 60%, C.
parapsilosis 20%, and C. tropicalis 20%. More uncommon species include Coccidioides immitis,
Sporothrix schenckii, and Blastomyces dermatitidis.
Figure 4. Preformed cement spacer with amphotericin B and fluconazole in a prosthesis with fungal infection.
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Immunosuppression, prolonged hospitalization, prolonged intravenous therapy, drug
dependence, and inflammatory diseases are risk factors for the development of fungal
infections; however, in most published cases the patients did not present these risk factors. A
reasonable postulate is that infection is caused by intraoperative inoculation rather than by
hematogenous spread. The symptoms are those of a subacute infection, namely, mild to
moderate pain or discomfort, effusion, and, occasionally, progressive osteolysis [51]. Publish‐
ed series are very short [52]-[54]. Phelan et al. [55] performed a 2-stage revision procedure with
systemic administration of antifungal agents to treat 4 Candida infections of total joint arthro‐
plasties. They also identified 6 other cases in the literature that had been treated with the same
regimen. In addition to resection arthroplasty, 8 patients received amphotericin B alone or in
combination with other antifungal agents, and 1 patient was treated with fluconazole in
monotherapy. Eight patients had no recurrence of infection at a mean of 50.7 months after
reimplantation.
4.4. Dose of antibiotic
Lewis [33] studied the properties of antibiotic-loaded cements. Elution typically occurs in 3
phases: an exponential phase (during the first 24 hours), a declining phase, and a final low
constant elution phase. The exponential phase depends on the diffusion area of the surface of
the spacer, although porosity and hydrophilicity of the cement also play a role. Porosity
determines the amount of liquid that comes into contact with the surface of the cement, which
in turn determines the elution rate of the antibiotic from the surface or from deeper cracks in
the cement.
The addition of high doses of antibiotic to the cement is a key element of treatment when
attempting to reach maximum intra-articular concentrations in the exponential phase,
although some authors have observed persistent effective levels of antibiotics until 4 months
after surgery [56].
The antibiotic should not exceed 20% of the total mass of cement. In addition, it should be in
powder form, since liquid forms hinder polymerization. No standard ideal dosage of each
drug to be mixed with bone cement has been established. Addition of 2 antibiotics to the cement
is superior to the addition of 1. The most frequently used doses vary from 2.4 g of tobramycin
with 1 g of vancomycin per 40 g of cement to 4 g of vancomycin with 4.6 g of tobramycin per
40 g of cement. These doses have been associated with success rates of above 90% [41], [56].
As the amount of antibiotic powder increases, the strength of the cement decreases. How‐
ever,  antibiotic load seems to be yet another factor within 2-stage exchange, and consis‐
tent  results  have  been  obtained  using  unloaded antibiotic  spacers  or  spacers  with  only
minimal loads. Fehring et al. [15] reported efficacious results with 1.2 g of tobramycin per
40 g of bone cement. Mean follow-up was 36 months for patients who received a nonarti‐
culating spacer (88% eradication) and 27 months for patients treated with an articulating
spacer (93% eradication).
Arthroplasty - Update564
4.5. Resistance: Mechanical properties of cement
The factors affecting the mechanical properties of the cement are type of cement, proportion
and combination of antibiotics, administration in liquid or powder form, and mixing method
(manual or vacuum). Cement mixed with cloxacillin, cefazolin, gentamicin, vancomycin, and
tobramycin has been shown to maintain good resistance to tension and compression [57], [58].
However,  adding liquid antibiotic  interferes with early polymerization,  leading to a sig‐
nificant  deterioration in the properties  of  the cement,  because of  the effect  of  the water
and not the properties of the antibiotic itself. For example, addition of liquid gentamicin
instead of powder can decrease the resistance of the cement to compression by 49% and
the tensile strength by 46%. Tobramycin powder, on the other hand, had not detrimental
effects on the spacers [59], [60].
Manually adding antibiotic also weakens the cement. Vacuum-mixed antibiotic-impregnated
cement improves its mechanical properties by reducing porosity by up to 20%. It has been
estimated that manual mixing causes a 30-40% reduction in resistance and that vacuum mixing
can reduce 10-fold the rate of fracture during cyclic loading with spacers [61], [62].
Commercial antibiotic-loaded cements retain their mechanical properties, although the dose
may not be sufficient for the treatment of an infection or for the manufacture of spacers, except
for some commercial forms, such as Copal.
Duncan [17] reported that manual mixing decreased resistance by 36% with respect to
commercially available cement, while the resistance of the latter did not differ from that of
nonloaded cement.
Lewis [33] compared several cements and their biomechanical properties after combination
with different antibiotics. The composition of the cement was a major factor. The elution rate
of vancomycin and tobramycin from Palacos RG is superior to that of Simplex, and the elution
rate of Simplex is superior to that of CMW. The combination of antibiotics is also important.
Vancomycin combined with tobramycin increases elution with Palacos (the same is true of
gentamicin), but with Simplex P, elution of tobramycin decreases, not vice versa. Vacuum
mixing also affects elution. CMW variants decrease elution of gentamicin when vacuum-
mixed; however, with Palacos the opposite occurs, as confirmed by a recent study [34]. The
concentration of vancomycin did not differ significantly depending on whether the cement
was mixed manually or by vacuum. These authors also studied the effect of loading and impact
cycles, which can lead to minor porosity and cracks in the spacer, thus increasing the elution
rate. Among the cements studied, elution only increased with Palamed G, whose porosity is
higher. For the remainder, no statistically significant differences were observed between load
and lack of impact on the patient.
Also important is the way in which the mixture is made. Hanssen and Spangehl [63] proposed
a method for adding high doses of antibiotics to bone cement powder. Polymethylmethacrylate
monomer and cement powder must first be mixed to form the liquid cement, and the antibiotic
is added afterwards. It is important to leave as many large crystals as possible intact in order
to create a more porous mix that increases the elution rate of the antibiotics.
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This approach is not applicable when using antibiotic-loaded cement prophylactically, as
crystals weaken the cement. Moreover, manual mixing decreases the elution rate in some types
of cement. Therefore, commercial forms are preferred.
The method of Frommelt and Kühn [64], namely, fractional addition of antibiotic (now
generally recommended), involves the gradual addition of cement and antibiotic powder and
mixture of the two until the expected load of antibiotic is complete. The mixture can then be
made manually or by vacuum, depending on the type of cement and the availability of vacuum
systems. Once mixed, the cement has to be applied in the doughy phase or late phase of
polymerization to prevent excessive interdigitation with the bone, thus facilitating extraction
during surgery and providing the surgeon with a certain degree of freedom to shape the
articular surface of the spacer.
4.6. Safety
As with any treatment, the surgeon must be aware of the possible side effects of the antibiotics
used in spacers. Despite the large number of infected arthroplasties treated annually and the
widespread use of antibiotic-loaded cement, complications are rare.
Evans [54] used 4 g of vancomycin and 4.6 g of tobramycin in powder per batch of 40 g of
polymethylmethacrylate cement in 44 patients with a total of 54 periprosthetic joint infections.
Follow-up to a minimum of 2 years showed no renal, vestibular, or auditory effects. Springer
et al. [43] studied the systemic safety of cement loaded with high doses of antibiotic over time
and reported that an average dose of 10.5 g of vancomycin and 12.5 g of gentamicin was
clinically safe, with no signs of acute renal failure or other systemic side effects. In contrast,
Van Raaij et al. [65] reported a case of acute renal failure that affected an 83-year-old woman
after treatment with 2 g of gentamicin in a 240-g cement block combined with 7 strings of
gentamicin-loaded polymethylmethacrylate beads. Serum levels of gentamicin were high,
leading to removal of the spacer and eventual recovery of renal function. Ceffa et al. [66]
reported 2 cases of mucormycosis after treatment with antibiotic-loaded cement spacers.
The complications reported are rare events in which other factors (eg, blood volume or
intravenous antibiotics) could play a role, since the normalization profile of serum antibiotic
levels, when using antibiotic-loaded spacers, is exponential and reaches normal values in 24
hours.
5. Results
The use of a polymethylmethacrylate antibiotic-loaded spacer provides not only more effective
treatment of periprosthetic infection, with eradication rates ranging from 90% to 100% in the
literature, but also improved function, reduced pain, greater patient satisfaction, shorter
hospital stay, and lower costs. Few studies analyze developments in the medium-to-long term.
Although the results remain more or less stable, up to 30% of patients require revision for
loosening, reinfection, or other causes in the medium term [67].
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Several studies compare the results of 2-stage exchange with articulating spacers and 28 studies
compare the results with a static spacer [3].
Park et al. [68] compared 20 prosthetic knee infections treated with monoblock spacers and 16
treated with articulating spacers. The reinfection rate was 6.3% for the articulating group and
15% for the fixed group. The range of motion with the spacer was 80º and 9º, respectively (final
range, 108º and 92º). The clinical and functional score according to the HSS scale was signifi‐
cantly better with the articulating spacer, and the number of extensile exposures was lower.
In the static spacer group, 75% of patients (65% of the femurs and 50% of the tibias) had bone
loss. This complication was not observed for the articulating spacers.
Meek et al. [27] retrospectively analyzed the results of 2-stage exchange with a PROSTALAC
articulating spacer in 47 patients with infected knee prosthesis and a mean follow-up of 41
months. The eradication rate was 96%. The Western Ontario and McMaster Universities
Osteoarthritis scale and the Oxford-12 and Short Form-12 scales showed better scores for
articulating spacers.
Calton et al. [9] compared the outcomes of patients treated with articulating spacers and
patients treated with nonarticulating spacers. Among the 24 patients with a nonarticulating
spacer, 60% had an average bone loss of 6.2 mm in the tibia and 12.8 mm in the femur, often
with invagination and migration of the spacer and problems of soft tissue retraction. The
authors recommended intramedullary extension of the spacer to prevent migration and obtain
the appropriate thickness. They also recommended tightening the collateral ligaments to
prevent contracture and a block that is sufficiently wide to rest on the cortical rim and prevent
migration to cancellous bone. No differences were observed between the groups in eradication
rates, time of surgery, or functional outcome.
Fehring et al. [15] studied 25 nonarticulating spacers and 30 articulating spacers and found
that articulating spacers facilitated reimplantation and were not associated with bone loss.
Emerson et al. [13] reported that range of motion was greater with articulating knee spacers
than with nonarticulating spacers; flexion of the knee averaged 107.8° and 93.7°, respectively,
and no evidence of higher complication rates was found.
Therefore, a comprehensive review of the literature provides more arguments for articulating
spacers than for static spacers. Articulating spacers seem to be the most widespread form of
treatment. The method of making the spacer does not seem to affect eradication rates or
functional outcome.
Durbhakula et al. [21] treated 4 patients with antibiotic-loaded articulating spacers made in
vacuum-injected silicone molds designed to produce articulating femoral and tibial compo‐
nents. The final average range of motion was 104° and the HSS score was 82. The rate of
eradication of infection was 92% after an average of 33 months. A system of this type does not
require a metal-polyethylene articulation surface and reduces costs by applying reusable
molds that cost about $300 each. The authors reported no problems of dislocation, retraction,
bone loss, fracture, or fragmentation of the spacer.
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Goldstein et al. [23] formed spacers intraoperatively using cement and test components on
aluminum foil to prevent interdigitation. The femoral condyles were molded with the tibial
trial implant, and the tibial implant was used to calculate the size and thickness of the cemented
tibial component. The authors reported initial success in 5 patients.
MacAvoy and Ries [20] described an inexpensive mold-based method for manufacturing a
spherical articulating spacer (ball and socket). They used this method in cases with severe bone
deficiency and damage to the ligaments because of its high congruence. The average load was
3.6 g to 4 g of tobramycin + 1 g of vancomycin per bag of Palacos. For an average of 4 cements,
this represents a dose of more than 14 g. In 12 patients with severe comorbidities, infection
was eradicated in 9 of 13 knees with a mean follow-up of 28 months. All patients could walk
with minimal assistance. The average range of motion of the knee with the spacer was 79°,
which increased to 98° at the end of treatment. The authors rarely used hinge models, despite
serious injury to the ligaments and bone loss.
Using cement spacer molds created intraoperatively with Palacos RG loaded with 0.5 g of
gentamicin plus 3 g of vancomycin, Shen et al. [25] obtained 10 reimplantations in 17 cases
followed for 30 months. In 5 cases, the spacer was the definitive treatment, in 1 case the joint
merged, and 1 patient required amputation. The average range of motion with the spacer was
82° (97° after reimplantation).
Excellent results have been reported with the Hoffman prosthesis-spacer system. Anderson et
al. [30] reported a range of motion of 2° to 115°; Huang et al. [69] reported 97.6°, which was
smaller than in previous publications (104º to 115º). As for eradication with this type of spacer,
reinfection rates are variable: 4% according to Anderson et al. [30] (25 knees), 0%-12% accord‐
ing to Hofmann et al. [29] (22 and 50 patients; Simplex cement with 4.8 g of vancomycin per
bag), 9% according to Emerson et al. [13] (22 patients), and 2% according to Cuckler [70] (44
patients).
Ha [24] reported motion ranging from 2° to 104° with manually modeled cement spacers. The
study included 12 cases treated with spacers made using the double mold (a cement negative
is made with trial components and the definitive spacer is modeled on the negative) and using
doses of 4.8 g of tobramycin and 4 g of vancomycin per cement bag. The antibiotic load
accounted for 20% of the cement-antibiotic composite.
In addition to the type of spacer, range of motion is influenced by preoperative mobility, the
state of the soft tissues, surgical technique, implant selection, early rehabilitation, and patient
cooperation. Our group [18] found the range of motion to be 107° after reimplantation using
manual spacers and 7.5% antibiotic load.
Soft tissue damage, severe bone loss or general health status, appear to be more important than
the treatment method, and the results of 2-stage exchange, which are generally excellent, are
much worse in patients with a less favorable health status.
Macmull et al. [71] published 19 cases with the SMILES spacer, which was based on an
antibiotic-loaded hinge coated with antibiotic-loaded cement (Palacos RG, Heraeus Medical
GmbH, Wehrheim, Germany). The spacer was used in the early stages of chronic infection
Arthroplasty - Update568
associated with severe bone loss on revision arthroplasty in 11 cases (58%), tumor endopros‐
theses in 4 (21%), primary arthroplasty in 2 (11%), and infection on fracture or osteotomy in 2.
The eradication rate at 38 months was 63% (12 cases), Four patients (21%) suffered reinfection
and 2 were amputees. Jeys et al. [72] reported an eradication rate of 72% in primary infection
of massive tumor prosthesis with a 2-stage protocol.
Reinfection after reimplantation has not been adequately studied in the literature, although
the high percentage of rescue treatments indicates that reinfection has its own prognostic
implications. Therefore, it could be classified as a separate type of infection and independently
studied in the future.
Hanssen et al. [73] published a series of 24 reinfections after infected total knee prosthesis. The
infection was eradicated in only 1 case. Another patient received suppressive therapy after a
new reimplantation, and the rest underwent arthrodesis.
Hart and Jones [74] reported 6 cases of reinfection following 2-stage revision. The infection
was eradicated in 2 cases (with another 2-stage revision), 2 patients had bone fusions, and 2
had suppressive treatments.
6. Conclusions
1. Two-stage exchange is considered the treatment of choice in the following circumstances:
late infection, unidentified causal microorganisms, fungal infections, infections by
virulent organisms, underlying inflammatory diseases, immunosuppression, and
reinfection after reimplantation.
2. Articulating spacers can minimize complications between procedures, thus enhancing
patient autonomy and mobility, preventing retraction of the soft tissues, and facilitating
reimplantation.
3. In addition, articulating spacers seem to improve eradication rates and functional
outcomes and reduce complications.
4. The way the spacer is constructed does not seem to affect eradication rates and functional
outcome. The surgeon’s choice of spacer will depend on technical and financial restraints.
Despite their advantages and disadvantages, all types of spacer have demonstrated
consistent and reproducible results.
5. Not all cements are equally suitable for the prevention and treatment of infection.
6. The antibiotic should be added as powder to avoid weakening the cement. Appropriate
use of synergies increases the spectrum of coverage and elution rate of certain antibiotics.
7. Once fractionated addition is complete, vacuum mixing increases the elution of the
antibiotic from the spacer when high-viscosity cements are used. Manual mixing is
preferred when low-viscosity cements are used.
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